Edition:
India

People: JCR Pharmaceuticals Co Ltd (4552.T)

4552.T on Tokyo Stock Exchange

6,850JPY
22 Jul 2019
Change (% chg)

¥90 (+1.33%)
Prev Close
¥6,760
Open
¥6,750
Day's High
¥6,920
Day's Low
¥6,710
Volume
103,100
Avg. Vol
113,828
52-wk High
¥7,350
52-wk Low
¥4,260

Sato, Yuji 

Mr. Yuji Sato was named Chief Director of Development and Director in JCR Pharmaceuticals Co., Ltd. effective June 2018. He joined the Company in December 2017. He previously served as Executive Officer in the Company. He used to work for MSD K.K. and Sanofi K.K.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --